Entropy Neurodynamics Limited has released a press release.
PLEXOVAL I study disrupted by the Covid-19 response
Filed with ASX ·
6ix hasn’t read this filing yet.
Entropy Neurodynamics Limited on 6ix
Earlier from Entropy Neurodynamics
- Appendix 4D and Interim Financial Report
- Cevaris testing shows positive results in bladder control
- Cevaris testing shows positive results in models of ED
- Independent Plexaris and Cevaris testing
- December Quarterly Report and Appendix 4C
Later from Entropy Neurodynamics
- March Quarterly Report and Appendix 4C
- Plexaris product engineered to deliver anti-cancer drug
- Shareholder Update
- Added IP empowers Exopharms engineered exosome pipeline
- June Quarterly Report and Appendix 4C
Follow Entropy Neurodynamics into a list and get an email when it puts out news.
Follow Entropy Neurodynamics